Oppenhoff advises Lange Medtech on the acquisition of the German medical technology company ErgoSurg

Oppenhoff has comprehensively advised the Chinese Lange Medtech Group on the acquisition of a majority stake in ErgoSurg GmbH. The previous managing shareholder of ErgoSurg will invested. The transaction was approved by the authorities at the end of 2024.

ErgoSurg is renowned for its research, development, and manufacturing of world-leading medical navigation and surgical robotic systems. Over its 20-year history, it has supplied numerous companies worldwide with advanced and reliable navigation and surgical robotic systems, including ODM/OEM products and services for several global leaders in niche industries.

Lange Medtech is a leading company in the medical technology industry in China. Headquartered in Shanghai, the company integrates research and development, manufacturing, distribution, and service, with a strong focus on minimally invasive orthopaedics and biomaterials. Lange Medtech aims to achieve a leading position in the field of orthopaedic surgery.

The Oppenhoff team led by Dr. Markus Rasner comprised Moritz Schmitz (both M&A), Lisa Zimmermann (corporate), Dr. Gunnar Knorr (tax), Anja Dombrowsky, Lisa Striegler (both employment law), Stephan Müller and Dr. Carsten Bormann (both foreign investment control). The transaction was advised together with Yuanda China Law Offices.

The M&A team of Oppenhoff regularly advises in the medical products and medical technology industry, most recently for example on the acquisition of Waldemar Knittel Glasbearbeitungs GmbH by the US-American StatLab Medical Products Group.

Back to list